Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits

Circulation

Volumn 96, Issue 6, 1997, Pages 1964-1969

  Bjarnason, Nina Hannover ^a,c   Haarbo, Jens ^a   Byrjalsen, Inger ^a   Kauffman, Raymond F ^b   Christiansen, Claus ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b ELI LILLY AND COMPANY   (United States)

^c CCBR   (Denmark)

Author keywords

Atherosclerosis; Estrogen; Lipids; Prevention; Raloxifene

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTROGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RALOXIFENE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL INTAKE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL;

EID: 0030806090     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.6.1964     Document Type: Article

References (34)

1. Bush TL, Fried LP, Barret-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem. 1988;34:B60-B70.
2. Bush TL. Extraskeletal effects of estrogen and the prevention of atherosclerosis. Osteoporos Int. 1991;2:5-11.
3. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
4. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-1593.
5. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, Frolik CA, Termine JD, Bryant HU. Raloxifene (LY139481HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest. 1994;93:63-69.
6. Draper MW, Flowers DE, Huster WJ, Neild JA, Harper KD, Arnaud C. A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women. J Bone Miner Res. 1996;11:835-842.
7. Gottardis MM, Jordan VC. Antitumor actions of keoxifene and tamoxifene in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res. 1987;47:4020-4024.
8. Kaplan HM, Timmons EH. The Rabbit: A Model for the Principles of Mammalian Physiology and Surgery. New York, NY: Academic Press Inc; 1979:127-129.
9. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
10. Arad Y, Badimon JJ, Badimon L, Hembree WC, Ginsberg HN. Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbits. Arteriosclerosis. 1989;9:159-166.
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-275.
12. Thorpe SM. Steroid receptors in breast cancer: sources of interlaboratory variation in dextran-charcoal assays. Breast Cancer Res Treat. 1987;9:175-189.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
14. Thorpe SM, Lykkesfeldt AE, Vinterby A, Lonsdorfer M. Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies. Cancer Res. 1986;46: 4251s-4255s.
15. Kushawa RS, Lewis DS, Carey KD, McGill HC. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.). Arterioscler Thromb. 1991;11: 23-31.
16. Clarkson TB, Adams MR, Kaplan JR, Shively CA, Koritnik DR. From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. Am J Obstet Gynecol. 1989;160: 1280-1285.
17. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
18. Kangas L. Agonistic and antagonistic effects of antiestrogens in different target organs. Acta Oncol. 1992;31:143-146.
19. Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science. 1996;273:1222-1225.
20. Dauvois S, White R, Parker MG. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci. 1993;106:1377-1388.
21. Bryant HU, Glasebrook AL, Yang NN, Sato M. A pharmacological review of raloxifene. J Bone Miner Metab. 1996;14:1-9.
22. Lin AL, McGill HC, Shain SA. Hormone receptors of the baboon cardiovascular system. Circ Res. 1982;50:610-616.
23. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20: 452-457.
24. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995;92:24-30.
25. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
26. Sulistiyani, Adelman SJ, Chandrasekaran A, Jayo J, St Clair RW. Effect of 17 alpha-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1995;15:837-846.
27. Ma PTS, Yamamoto T, Goldstein JL, Brown MS. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17β-ethinyl estradiol. Proc Natl Acad Sci U S A. 1986;83:792-796.
28. Haarbo J, Christiansen C. The impact of female sex hormones on secondary prevention of atherosclerosis in ovariectomized, cholesterol-fed rabbits. Atherosclerosis. 1996;123:139-144.
29. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfalusy U, Berglund L, Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest. 1989;19:395-403.
30. Adams MR, Kaplan JR, Manuck SB, Korotnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1657.
31. Williams JK, Honoré EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 1994;7: 1757-1761.
32. Williams JK, Anthony MS, Honoré EK, Herrington DM, Morgan TM, Register TC, Clarkson TB. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 1995;15:827-836.
33. Ravnikar VA. Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Womens Health Issues. 1992;2:75-80; discussion, 80-82.
34. Recker RR. Clinical review 41: current therapy for osteoporosis. J Clin Endocrinol Metab. 1993;76:14-16.